Adenovirus-mediated wild-type P53 Transfer radiosensitizes H1299 cells to subclinical-dose carbon-ion irradiation through the restoration of p53 function

To determine whether adenovirus-mediated wild-type p53 transfer after radiotherapy could radiosensitize non-small-cell lung cancer (NSCLC) cells to subclinical-dose carbon-ion beam (C-beam), H1299 cells were exposed to a C-beam or -ray and then infected with 5 MOI of AdCMV-p53 or GFP (C-beam or -ray with p53 or GFP).Cell cycle was detected by flow cytometric analysis. The apoptosis was examined by a fluorescent microscope with DAPI staining. DNA fragmentation was monitored by the TUNEL assay. P53 mRNA was detected by reverse-transcriptase polymerase chain reaction. The expression of p53, MDM2, and p21 was monitored by Western blot. Survival fractions were determined by colony-forming assay. The percentages of G1-phase cells in C-beam with p53 increased by 8.2%–16.0%, 5.2%–7.0%, and 5.8%–18.9%, respectively, compared with C-beam only, -ray with p53, or p53 only. The accumulation of G2-phase cells in C-beam with p53 increased by 5.7%–8.9% and 8.8%–14.8%, compared with those in -ray with p53 or p53 only, respectively. The percentage of apoptosis for C-beam with p53 increased by 7.4%–19.1%, 5.8%–11.7%, and 5.2%–19.2%, respectively, compared with C-beam only, -ray with p53, or p53 only. The level of p53 mRNA in C-beam with p53 was significantly higher than that in p53 only. The expression level of p53 and p21 in C-beam with p53 was significantly higher than that in both C-beam with GFP and p53 only. The survival fractions for C-beam with p53 were significantly less than those for the other groups (p 0.05). The data suggested that AdCMV-p53 transfer could more efficiently radiosensitize H1299 cells to subclinical-dose C-beam irradiation through the restoration of p53 function.

High-efficiency transfer and expression of AdCMV-p53 in human cervix adenocarcinoma cells induced by subclinical-dose carbon beam radiation

Purpose The aim of this study is to evaluate the eVect of carbon-beam irradiation on adenovirus-mediated p53 transfer in human cervix adenocarcinoma.Materials and methods The HeLa cells pre-exposed to carbon-beam or -ray, were infected with replication-deficient adenovirus recombinant vectors, containing human wild-type p53 (AdCMV-p53) and green Xuorescent protein (GFP) (AdCMV–GFP), respectively. The GFP transfer and p53 expression were detected by Xow cytometric analysis.Results The GFP transfer frequency in C-beam with AdCMV-GFP groups was 38–50% more than that inγ-ray with AdCMV–GFP groups. The percentage of p53 positive cells in the C-beam with AdCMV–p53 groups was 34–55.6% more than that in γ-ray with AdCMV-p53 groups (p < 0.05), suggesting that subclinical-dose C-beam irradiation could signiWcantly promote exogenous p53 transfer and p53 expression, and extend the duration of p53 expression in the HeLa cells. The expression of p21 increased with p53 expression in HeLa cells. The survival fractions for the 0.5–1.0 Gy C-beam with AdCMV-p53 groups were 38–43% less than those for the isodose γ-ray with AdCMV-p53 groups, and 31–40% less than those for the C-beam only groups (p <0.05).Conclusions The subclinical-dose C-beam irradiation could signiWcantly promote the transfer and expression of exogenous p53, extend the duration of p53 expression, and enhance the suppression of p53 on cervix adenocarcinoma cells.

低剂量碳离子束辐射增强AdCMV-p53转染对非小细胞肺癌细胞的治疗效果

探讨低剂量碳离子束预辐照对AdCMV-p53转染非小细胞肺癌细胞的影响, 观察了20和40 MOI AdCMV-p53转染经12C6+ 束流或γ 射线预辐照的H1299细胞后, 外源性p53的表达、细胞周期、细胞凋亡和细胞存活等. 结果显示, 经碳离子束预辐照后 AdCMV-p53转染细胞p53阳性细胞所占比例高达90%多, 明显高于γ 射线预辐射后AdCMV-p53 转染细胞p53阳性率. 低剂量碳离子预辐照明显阻止AdCMV-p53转染细胞G0/G1阻滞的发生,促进 G2/M 阻滞和细胞凋亡的发生. 碳离子束辐射诱导 AdCMV-p53 转染组相对生物学效应(RBE)比单纯碳离子束辐照组增加 30%~60%, 比单纯 AdCMV-p53 转染组增加20%~130%, 比单纯γ 辐射诱导 AdCMV-p53 转染组增加 30%~70%. 结论: 低剂量碳离子束预照射明显增强外源性 p53 的表达和AdCMV-p53 转染对非小细胞肺癌细胞的抑制.

低剂量碳离子束辐射增强AdCMV-p53转染对人非小细胞肺癌细胞的治疗效果

探讨低剂量碳离子束预辐照对AdCMV-p53转染非小细胞肺癌细胞的影响,观察了20和40MOIAdCMV-p53转染经12C6+束流或γ射线预辐照的H1299细胞后,外源性p53的表达、细胞周期、细胞凋亡和细胞存活等.结果显示,经碳离子束预辐照后AdCMV-p53转染细胞p53阳性细胞所占比例高达90%多,明显高于γ射线预辐射后AdCMV-p53转染细胞p53阳性率.低剂量碳离子预辐照明显阻止AdCMV-p53转染细胞G0/G1阻滞的发生,促进G2/M阻滞和细胞凋亡的发生.碳离子束辐射诱导AdCMV-p53转染组相对生物学效应(RBE)比单纯碳离子束辐照组增加30%~60%,比单纯AdCMV-p53转染组增加20%~130%,比单纯γ辐射诱导AdCMV-p53转染组增加30%~70%.结论:低剂量碳离子束预照射明显增强外源性p53的表达和AdCMV-p53转染对非小细胞肺癌细胞的抑制.

p53腺病毒重组体转染对p53缺失肿瘤细胞辐射敏感性的影响

目的观察p53腺病毒重组体(AdCMV-p53)转染对p53缺失肿瘤细胞辐射敏感性的影响。方法用腺病毒重组体(AdCMV-p53/GFP)转染经0、0.25、0.5、1.0、1.5、2.0Gyγ射线辐射的H1299(nullp53)和PC-3(nullp53)细胞,用流式细胞分析法检测外源性p53表达,用克隆形成法检测肿瘤细胞增殖能力。结果辐射联合AdCMV-p53转染组p53阳性细胞所占比例均明显高于单纯辐射组、单纯AdCMV-p53转染组和辐射联合AdCMV-GFP转染组同种细胞p53阳性率(P<0.05);AdCMV-p53转染不仅明显提高肿瘤细胞辐射敏感性,而且与肿瘤细胞组织来源有关。结论p53腺病毒重组体转染对p53基因缺失肿瘤细胞低剂量辐射敏感性的增强作用与肿瘤细胞来源的组织器官和细胞类型有关。

P53及其相关蛋白对X射线照射肝癌细胞周期的调节

X射线照射人肝癌细胞HepG2,照射后细胞存活随照射剂量增大明显下降。流式细胞术分析,不同剂量组照射后24h均发生G2期阻滞。照射后不同时间组的细胞周期分布也有不同,照射后12h,有显著的S期延迟。Western Blot显示照射后24hP53,MDM2,P21蛋白表达上升,并有时间效应:P53在照射后24h之内始终维持较高表达,MDM2和P21分别在照射后6和12h的表达最高。X射线照射通过影响P53及其相关蛋白的表达影响细胞周期。

辐射诱导促进AdCMV-p53转染前列腺癌细胞

用腺病毒重组体(AdCMV-p53/GFP)转染经0.5,1.0和2.0Gyγ射线辐射处理的前列腺癌细胞[PC-3(nullp53)],用克隆形成法检测细胞增殖能力,用流式细胞分析法测定腺病毒重组体转染率和外源性p53蛋白表达。结果提示,辐射诱导使腺病毒重组体转染PC-3细胞提高7%—39%。辐射联合AdCMV-p53转染组p53表达水平提高18.5%—35.4%。与单纯AdCMV-p53转染组和单纯辐射组相比,辐射联合AdCMV-p53转染组细胞存活率分别降低25%—64%和22%—65%。

辐射联合p53腺病毒重组体转染对肿瘤细胞的影响

以绿色荧光蛋白腺病毒重组体(Replication deficient adenovirus green fluorescence protein recombinant,AdCMV-GFP)为对照,用p53腺病毒重组体(Replication deficient adenovirus p53 recombinant,AdCMV-p53)转染经0、0.25、0.5、1.0、1.5和2.0Gyγ射线预辐射的HepG2(wtp53)、Hela(wtp53,wtP53低水平表达)和HT-29(mtp53,mtP53过表达)细胞,用克隆形成法检测肿瘤细胞存活,探讨AdCMV-p53转染对p53基因状态与功能不同肿瘤细胞辐射敏感性的影响。结果显示,AdCMV-p53转染不仅明显提高肿瘤细胞辐射敏感性,而且与肿瘤细胞内在p53基因状态与功能有关。

碳离子辐射对人肝癌细胞SMMC-7721细胞周期和P53、MDM2及P21表达的影响

研究12C6+离子辐照对体外培养人肝癌细胞SMMC-7721细胞周期和P53、MDM2及P21表达的影响。采用0、1.0、2.0、4.0、6.0Gy12C6+离子束辐照细胞,用克隆形成法观察细胞存活情况;同时在辐照24h后用流式细胞仪检测细胞周期的变化,Western-blot检测细胞中P53、MDM2及P21蛋白表达情况。结果发现,重离子辐照后细胞存活率显著下降;1.0Gy、4.0Gy和6.0Gy照射组发生G0/G1期阻滞,而2.0Gy照射组出现G2/M期阻滞;Western-blot结果显示细胞辐照后MDM2的57kD蛋白表达水平无明显变化,而76kD蛋白表达水平随辐照剂量逐渐上升;P53和P21蛋白表达水平随辐照剂量增高。以上结果提示不同剂量的12C6+离子束照射可激活SMMC-7721细胞不同的细胞周期检测点,其中G0/G1期阻滞与P53和P21蛋白以及MDM2截短体76kD蛋白的表达水平升高有关。

p53基因转导联合放射治疗恶性肿瘤的研究进展

肿瘤治疗是目前医学研究的重点方向,其方法包括传统的放疗、化疗、手术以及目前热门的各种基因治疗等,各有其优缺点。而p53基因治疗与放射治疗方法的结合越来越受到重视。综述了近年来p53基因转导联合放射治疗恶性肿瘤的研究结果以及可能的作用机理及进展。

辐射诱导增强p53重组腺病毒转染对人结直肠癌细胞的抑制

探讨了辐射诱导对p53重组腺病毒载体转染p53突变型结直肠癌细胞(HT-29细胞系)的影响。以复制缺陷型重组腺病毒载体(AdCMV-GFP)为对照,用复制缺陷型p53重组腺病毒载体(AdCMV-p53)转染经0.5、1.0、2.0Gyγ射线照射的HT-29细胞,用流式细胞分析法检测细胞凋亡和p53蛋白表达,并用克隆形成法测定细胞增殖能力。结果表明,0.5Gy辐射诱导明显提高了AdCMV-p53转染对HT-29细胞的抑制,促进细胞凋亡。0.5Gy辐射诱导对AdCMV-p53转染HT-29细胞的抑制杀伤的增强作用最强,0.5Gy辐射诱导及40MOI和80MOIAdCMV-p53转染对肿瘤的抑制率比同等剂量下单纯转染组分别提高约50%和20%,比0.5Gy单纯辐照组提高40%。因此,0.5Gy辐射诱导可有效增加低于80MOIAdCMV-p53转染对HT-29细胞的抑制作用。辐射诱导AdCMV-p53转染HT-29细胞以最大辐射剂量不超过1.0Gy及AdCMV-p53转染量低于80MOI为宜。

辐射诱导p53腺病毒重组体转染对结直肠癌细胞周期的影响

以复制缺陷型重组腺病毒载体(AdCMV-GFP)为对照,用复制缺陷型p53重组腺病毒载体 (AdCMV-p53)转染经0．5、1．0、2．0Gyγ射线照射的HT-29细胞,克隆形成法检测对细胞的抑制作用,流式细胞分析法检测细胞周期和细胞凋亡,探讨辐射诱导对AdCMV-p53转染p53突变型结直肠癌细胞(HT-29细胞系)细胞周期的影响。结果显示,0．5-1．0Gy辐射诱导明显增强40 MOI AdCMV-p53转染对HT-29细胞的抑制。与AdCMV-p53转染对照相比,1 d后,辐射诱导转染组G0／G1期细胞减少5%-15％,S期细胞增加 2%-19％,2．0Gy辐射诱导80 MOI AdCMV-p53转染组G2/M期细胞增加12％;3d后,0．5、1．0Gy辐射诱导40 MOI AdCMV-p53转染组G2／M期细胞分别增加10%-13％。辐射诱导AdCMV-p53转染组细胞凋亡与辐射诱导剂量和AdCMV-p53转染剂量相关。以上结果表明,辐射诱导加速AdCMV-p53转染细胞由G0／G1期到S期的进程,促进S期阻滞和G2/M期阻滞发生。